Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Intravaginal Metronidazole for Bacterial Vaginosis
NCT00741845Phase 3Terminated
- Sponsor
- Embil Pharmaceuticals
- Start
- Jun 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metronidazole in bacterial vaginosis (BV), sponsored by Embil Pharmaceuticals. Started Jun 2008; status: terminated.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT00741845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00741845.